Hostname: page-component-586b7cd67f-rdxmf Total loading time: 0 Render date: 2024-11-25T10:04:39.787Z Has data issue: false hasContentIssue false
  • English
  • Français

Authors' reply

Published online by Cambridge University Press:  02 January 2018

M. Hotopf  and
G. Lewis
M. Hotopf
Affiliation:
Department of Psychological Medicine, Institute of Psychiatry, 103 Denmark Hill, London SE5 8AZ
G. Lewis
Affiliation:
Lewis University of Wales School of Medicine, Heath Park, Cardiff
Get access Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Columns
Information
The British Journal of Psychiatry , Volume 170 , Issue 1 , January 1997 , pp. 88
Copyright
Copyright © 1997 The Royal College of Psychiatrists 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Freemantle, N., House, A., Song, F., et al (1994) Prescribing selective serotonin reputake inhibitors as a strategy for prevention of suicide British Medical Journal, 309, 249–253.Google Scholar
Jick, S. S., Dean, A. D. & Jick, H. (1995) Antidepressants and suicide. British Medical Journal. 310, 215–218.CrossRefGoogle Scholar
Submit a response

eLetters

No eLetters have been published for this article.